Praveen Anand
Overview
Explore the profile of Praveen Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
3456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar A, Singh A, Anand P, Pandey D, Gupta S, K L, et al.
Indian J Pediatr
. 2025 Feb;
PMID: 39899196
Objectives: To assesses the coverage, adherence, reasons for non-initiation and non-completion of tuberculosis preventive treatment (TPT) among household child contacts (HHCC) of pulmonary tuberculosis (TB). Methods: This cross-sectional study was...
2.
Waldschmidt J, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, et al.
Blood Adv
. 2025 Jan;
9(5):1132-1136.
PMID: 39813623
No abstract available.
3.
Sloan G, Donatien P, Privitera R, Shillo P, Caunt S, Selvarajah D, et al.
Front Pain Res (Lausanne)
. 2024 Nov;
5:1485420.
PMID: 39512388
Background: Identifying distinct mechanisms and biomarkers for painful diabetic peripheral neuropathy (DPN) is required for advancing the treatment of this major global unmet clinical need. We previously provided evidence in...
4.
Shillo P, Sloan G, Selvarajah D, Greig M, Gandhi R, Anand P, et al.
Diabetes
. 2024 May;
73(8):1317-1324.
PMID: 38776434
Article Highlights:
5.
Hernandez-Lopez P, Vijaykumar T, Anand P, Auclair D, Frede J, Knoechel B, et al.
Blood Adv
. 2024 Apr;
8(12):3173-3185.
PMID: 38603572
Although most patients with multiple myeloma respond to treatment initially, therapy resistance develops almost invariably, and only a subset of patients show durable responses to immunomodulatory therapies. Although the immune...
6.
Anand U, Anand P, Sodergren M
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003528
Terpenes in exert analgesic effects, but the mechanisms are uncertain. We examined the effects of 10 terpenes on capsaicin responses in an established model of neuronal hypersensitivity. Adult rat DRG...
7.
Iyer P, Sachdeva K, Leggett C, Codipilly D, Abbas H, Anderson K, et al.
Clin Transl Gastroenterol
. 2023 Sep;
14(10):e00637.
PMID: 37698203
Introduction: Screening for Barrett's esophagus (BE) is suggested in those with risk factors, but remains underutilized. BE/esophageal adenocarcinoma (EAC) risk prediction tools integrating multiple risk factors have been described. However,...
8.
Murugadoss K, Niesen M, Raghunathan B, Lenehan P, Ghosh P, Feener T, et al.
PNAS Nexus
. 2023 Jan;
1(1):pgac018.
PMID: 36712796
Highly transmissible or immuno-evasive SARS-CoV-2 variants have intermittently emerged, resulting in repeated COVID-19 surges. With over 6 million SARS-CoV-2 genomes sequenced, there is unprecedented data to decipher the evolution of...
9.
Koo P, Ploenzke M, Anand P, Paul S, Majdandzic A
Methods Mol Biol
. 2023 Jan;
2586:197-215.
PMID: 36705906
Deep neural networks have demonstrated improved performance at predicting sequence specificities of DNA- and RNA-binding proteins. However, it remains unclear why they perform better than previous methods that rely on...
10.
Venkatakrishnan A, Anand P, Lenehan P, Ghosh P, Suratekar R, Silvert E, et al.
Sci Rep
. 2023 Jan;
13(1):257.
PMID: 36604461
The emergence of highly transmissible SARS-CoV-2 variants and vaccine breakthrough infections globally mandated the characterization of the immuno-evasive features of SARS-CoV-2. Here, we systematically analyzed 2.13 million SARS-CoV-2 genomes from...